Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2314635
Max Phase: Preclinical
Molecular Formula: C26H40Cl2N2O2S3
Molecular Weight: 508.82
Molecule Type: Small molecule
Associated Items:
ID: ALA2314635
Max Phase: Preclinical
Molecular Formula: C26H40Cl2N2O2S3
Molecular Weight: 508.82
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COCCc1sc[n+](CCCCc2ccc(CCCC[n+]3csc(CCOC)c3C)s2)c1C.[Cl-].[Cl-]
Standard InChI: InChI=1S/C26H40N2O2S3.2ClH/c1-21-25(13-17-29-3)31-19-27(21)15-7-5-9-23-11-12-24(33-23)10-6-8-16-28-20-32-26(22(28)2)14-18-30-4;;/h11-12,19-20H,5-10,13-18H2,1-4H3;2*1H/q+2;;/p-2
Standard InChI Key: YEHCCSABXMGEAA-UHFFFAOYSA-L
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 508.82 | Molecular Weight (Monoisotopic): 508.2241 | AlogP: 5.49 | #Rotatable Bonds: 16 |
Polar Surface Area: 26.22 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -1.00 | CX LogD: -1.00 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.19 | Np Likeness Score: -0.38 |
1. Caldarelli SA, El Fangour S, Wein S, Tran van Ba C, Périgaud C, Pellet A, Vial HJ, Peyrottes S.. (2013) New bis-thiazolium analogues as potential antimalarial agents: design, synthesis, and biological evaluation., 56 (2): [PMID:23289711] [10.1021/jm3014585] |
Source(1):